ABOUT US
X-Chem is redefining small molecule drug discovery through a powerful combination of computational sciences, discovery chemistry and data-driven insight. As the pioneer and global leader in DNA-encoded library (DEL) technology, X-Chem provides the foundation for smarter hit identification, accelerated lead progression and greater confidence in early discovery.
Learn more at www.x-chemrx.com.
FEATURED ARTICLES
-
![GettyImages-1347856181 assay, pipette]( "Covalent Warhead Reactivity: A New Look At GSH Reactivity Assays")
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
![GettyImages-1440940383-chemical-bonds-3d-structure]( "Flow Chemistry For Contemporary Isotope Labeling")
Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications.
-
![dna, rna molecules-GettyImages-537327406]( "Mirror, Mirror Makes RNA-targeted Discovery Smarter")
Examine a mirror‑image screening approach that eliminates DNA:RNA hybridization, revealing true binders and unlocking clearer, more productive DEL results for challenging RNA targets.
CONTACT INFORMATION
X-Chem
100 Beaver Street, Suite 101
Waltham, MA 02453
UNITED STATES
Contact: Lisa Yoder
FEATURED VIDEOS
-
![Combing Artificial Intelligence And DNA-Encoded Libraries]( "What Are The Benefits Of Combing AI And DELs For Drug Discovery?")
Discover how AI-powered modeling uncovers hidden patterns in DEL data, broadens chemical diversity, and accelerates decision-making to help teams prioritize compounds and move more efficiently.
FEATURED SOLUTIONS
-
![DEL]( "Discover Our DNA-Encoded Library (DEL) Technology")
Discover how DNA barcoding enables rapid screening of vast chemical space in early drug discovery, as well as how DEL platforms test billions of compounds efficiently.
-
![DNA double helix,Human DNA-GettyImages-1912348507]( "Small Molecule Exponential Discovery")
Explore how a data‑driven discovery model combines DEL screening, computational insights, and medicinal chemistry to accelerate hit‑to‑lead decisions, reduce risk, and enable efficient progression.
-
![GettyImages-474436406-chemical-equations-bonds]( "Turning Screening Data Into Discovery Direction")
Chemomics transforms full DEL datasets into predictive insights. See how combining large-scale screening with clear computational models accelerates SAR understanding and strengthens confidence.
